Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiemetics for PONV in Bariatric Surgery
NCT05087615Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ondansetron, metoclopramide and granisetron in postoperative nausea and vomiting (PONV) (5 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at Day 2. Started Mar 2021; status: completed.
02
Drugs
ondansetronmetoclopramidegranisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05087615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05087615.